Peyrin L
UA CNRS 1196, Laboratoire de Physiologie A, Faculté de Médecine, Lyon, France.
J Neural Transm Gen Sect. 1990;80(1):51-65. doi: 10.1007/BF01245022.
Measurement of total (free + conjugated) 3 methoxy-4-hydroxyphenylglycol (MHPG) in urine has long been used to assess the metabolism of central norepinephrine (NE). However, available data indicate that total MHPG is not a sensitive marker because the portion of urinary MHPG which derives from brain NE is less than was previously assumed. Several arguments support the view that central MHPG excretion is best represented by the urinary MHPG sulfate fraction. Accordingly, a new strategy has been introduced in last years, involving the separate determination of sulfate and glucuronide conjugates of MHPG as respective markers of central and peripheral NE metabolism. Various biochemical and pharmacological data obtained in healthy subjects and in patients with mental diseases support this hypothesis.
长期以来,尿液中总(游离 + 结合)3 - 甲氧基 - 4 - 羟基苯乙二醇(MHPG)的测量一直被用于评估中枢去甲肾上腺素(NE)的代谢。然而,现有数据表明,总MHPG并非敏感标志物,因为尿中源自脑NE的MHPG部分比之前认为的要少。有几个论据支持这样一种观点,即中枢MHPG排泄最好由尿中MHPG硫酸盐部分来代表。因此,近年来引入了一种新策略,涉及分别测定MHPG的硫酸盐和葡萄糖醛酸结合物,作为中枢和外周NE代谢的各自标志物。在健康受试者和精神疾病患者中获得的各种生化和药理学数据支持这一假设。